GenesisCare

Industry / private company


Location: Denmark, Australia (AU) AU

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases (2024) Ugurluer G, Schneiders FL, Corradini S, Boldrini L, Kotecha R, Kelly P, Portelance L, et al. Journal article A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer (2021) Kaidar-Person O, Dahn HM, Nichol AM, Boersma LJ, de Ruysscher D, Meattini I, Pignol JP, et al. Journal article INTERNATIONAL EXPERT DELPHI CONSENSUS GUIDELINES FOR THE USE OF BOLUS IN POST MASTECTOMY RADIATION THERAPY (2021) Dahn H, Boersma L, De Ruysscher D, Meattini I, Offersen B, Pignol JP, Aristei C, et al. Conference contribution THE USE OF BOLUS IN POSTMASTECTOMY RADIATION THERAPY FOR BREAST CANCER: A SYSTEMATIC REVIEW (2021) Dahn H, Boersma L, De Ruysscher D, Meattini I, Offersen B, Pignol JP, Belkacemi Y, et al. Journal article